Detailed Information
Cited 15 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Updated analysis with longer follow up of a phase 2a study evaluating erdafitinib in Asian patients (pts) with advanced cholangiocarcinoma (CCA) and fibroblast growth factor receptor (FGFR) alterations
- Authors
- Feng, YH[Feng, Yin-Hsun]; Su, WC[Su, Wu-Chou]; Oh, DY[Oh, Do-Youn]; Shen, L[Shen, Lin]; Kim, KP[Kim, Kyu-Pyo]; Liu, XF[Liu, Xiufeng]; Liao, HM[Liao, Huimin]; Qing, M[Qing, Min]; Qian, JQ[Qian, Jiaqi]; Triantos, S[Triantos, Spyros]; Sweiti, H[Sweiti, Hussein]; Park, JO[Park, Joon Oh]
- Issue Date
- 1-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 4
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.